|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 355.20 USD | +0.32% |
|
+1.61% | +8.52% |
| 08:19pm | Amgen owes $20.2 million in antibody patent lawsuit, US jury says | RE |
| 06-12 | Wall Street Wants to Believe Again |
| Market Cap | 192B 166B 153B 143B 268B 18,222B 272B 1,802B 702B 8,869B 719B 704B 30,709B | P/E Ratio 2026 * |
23.1x | P/E Ratio 2027 * | 21x |
|---|---|---|---|---|---|
| Enterprise Value | 233B 201B 185B 174B 325B 22,141B 330B 2,189B 854B 10,777B 874B 856B 37,314B | EV / Sales 2026 * |
6.16x | EV / Sales 2027 * | 5.85x |
| Free-Float |
99.78% | Yield 2026 * |
2.84% | Yield 2027 * | 3% |
Last Transcript: Amgen Inc.
| 1 day | +0.32% | ||
| 1 week | +1.61% | ||
| Current month | +5.47% | ||
| 1 month | +5.62% | ||
| 3 months | -3.42% | ||
| 6 months | +11.79% | ||
| Current year | +8.52% |
| 1 week | 337.49 | 358.46 | |
| 1 month | 320.96 | 358.46 | |
| Current year | 318.21 | 391.29 | |
| 1 year | 267.83 | 391.29 | |
| 3 years | 218.44 | 391.29 | |
| 5 years | 198.64 | 391.29 | |
| 10 years | 133.64 | 391.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 2019-12-31 |
Esteban Santos
COO | Chief Operating Officer | 59 | 2016-07-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-18 | Free | Director | 665 | 0.0001% | ||
| 05-18 | Free | Director | 665 | 0.0001% | ||
| 05-18 | Free | Director | 665 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.32% | +1.61% | +19.48% | +63.42% | 192B | ||
| -2.41% | +0.14% | +39.53% | +154.43% | 1,010B | ||
| +1.07% | +3.48% | +53.75% | +50.64% | 580B | ||
| +1.32% | +0.22% | +18.35% | +65.35% | 402B | ||
| +0.77% | 0.00% | +19.99% | +16.80% | 330B | ||
| -1.42% | -1.44% | +45.50% | +8.37% | 294B | ||
| -0.85% | -2.86% | +22.05% | +13.80% | 280B | ||
| +0.44% | +3.48% | +24.48% | +34.39% | 281B | ||
| +1.66% | +1.20% | -44.67% | -47.49% | 197B | ||
| -0.22% | -2.76% | +12.08% | +61.30% | 156B | ||
| Average | -0.28% | +0.61% | +21.05% | +42.10% | 372.3B | |
| Weighted average by Cap. | -0.78% | +0.84% | +29.10% | +65.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.79B 32.64B 30.08B 28.16B 52.77B 3,592B 53.58B 355B 138B 1,749B 142B 139B 6,054B | 38.75B 33.47B 30.84B 28.87B 54.11B 3,683B 54.94B 364B 142B 1,793B 145B 142B 6,208B |
| Net income | 8.26B 7.14B 6.58B 6.16B 11.54B 786B 11.72B 77.67B 30.28B 382B 31.02B 30.36B 1,324B | 9.04B 7.81B 7.2B 6.74B 12.62B 859B 12.82B 84.96B 33.13B 418B 33.93B 33.21B 1,448B |
| Net Debt | 41.23B 35.61B 32.82B 30.72B 57.57B 3,919B 58.46B 387B 151B 1,908B 155B 151B 6,605B | 35.08B 30.3B 27.92B 26.14B 48.98B 3,335B 49.74B 330B 129B 1,623B 132B 129B 5,620B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 355.20 $ | +0.32% | 2,730,230 |
| 26-06-11 | 354.06 $ | +4.84% | 4,727,125 |
| 26-06-10 | 337.73 $ | -1.98% | 3,000,395 |
| 26-06-09 | 344.56 $ | -0.34% | 3,388,246 |
| 26-06-08 | 345.73 $ | -1.10% | 2,488,219 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions

















